Thermo Fisher Scientific Long-Term Debt increased by 1.0% to $35.85B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 23.4%, from $29.06B to $35.85B. Over 5 years (FY 2020 to FY 2025), Long-Term Debt shows an upward trend with a 10.5% CAGR.
An increase indicates higher financial leverage, which can amplify returns on equity but also increases interest expense and financial risk.
Loans and financial obligations with a maturity period exceeding one year, typically consisting of corporate bonds and n...
Capital-intensive firms or those with aggressive share buyback programs often carry higher long-term debt than asset-light competitors.
long_term_debt| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.78B | $21.60B | $34.67B | $33.06B | $30.06B | $28.94B | $34.28B | $35.05B | $33.81B | $35.08B | $34.73B | $35.39B | $35.20B | $35.11B | $29.06B | $33.99B | $35.03B | $35.48B | $35.85B |
| QoQ Change | — | +15.0% | +60.5% | -4.6% | -9.1% | -3.7% | +18.4% | +2.3% | -3.6% | +3.8% | -1.0% | +1.9% | -0.6% | -0.2% | -17.2% | +17.0% | +3.1% | +1.3% | +1.0% |
| YoY Change | — | — | — | — | +60.1% | +34.0% | -1.1% | +6.0% | +12.5% | +21.2% | +1.3% | +1.0% | +4.1% | +0.1% | -16.3% | -4.0% | -0.5% | +1.1% | +23.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.